Fraunhofer Institute for Cell Therapy and Immunology IZI

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the institute‘s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharma­ceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products for the business units Cell and Gene Therapy, Drugs and Diagnostics. Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. In these areas, research specifically focusses on the indications oncology, immunological diseases as well as infectious diseases and neurodegenerative diseases.

The institute works in close cooperation with hospital institutions and performs quality tests besides carrying out the GMP-compliant manufacture of clinical test samples. Furthermore, it helps partners obtain manufacturing licenses and permits.

News

Latest press releases

19.11.2020

Rapid diagnostic device for trachoma eye infection delivers first promising result

A molecular biological, chip-based rapid test for the diagnosis of the eye infection trachoma developed at the Fraunhofer Institute for Cell Therapy and Immunology IZI has proven promising in first studies. The results of the study carried out together with the London School of Hygiene & Tropical Medicine and the Kilimanjaro Christian Medical Centre, Tanzania, have now been published in the journal "Parasites & Vectors". The development of the DjinniChip was supported by the ClearTrachoma project of the non-profit organization Task Force for Global Health in a program of the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD).
Read more

5.10.2020

Fraunhofer IZI presents new technologies and services for the healthcare industry at the Fraunhofer Solution Days

The first Fraunhofer Solution Days will take place digitally from October 26 to 29, 2020. The online event of the Fraunhofer-Gesellschaft is dedicated to the four topics health, digital economy, plant and mechanical engineering and mobility. The Fraunhofer Institute for Cell Therapy and Immunology IZI is participating with various exhibits and lectures, particularly in the field of health.
Read more

30.9.2020

Viromers suitable as carrier systems for gene-based treatment of inflammatory diseases

A project team from the Fraunhofer Institute for Cell Therapy and Immunology IZI and Lipocalyx GmbH (today: BioNTech Delivery Technologies GmbH) has now been able to prove that viromers are a suitable carrier material for messenger RNA (mRNA). In studies, the viromers developed by Lipocalyx proved to be a suitable therapeutic option for mRNA delivery in the treatment of a model for inflammatory diseases. The results were published in "Scientific Reports", an open access journal of the Nature Publishing Group.
Read more

15.9.2020

Fraunhofer IZI cooperates with Nomad Bioscience to develop novel anti-bacterial and anti-viral medications

The Fraunhofer Institute for Cell Therapy and Immunology (IZI) will, in future, cooperate with Nomad Bioscience GmbH in developing anti-bacterial and anti-viral medications. The Fraunhofer IZI Department of Drug Design and Target Validation based in Halle (Saale) and the company with headquarters in Munich concluded a relevant research and development agreement in July 2020.
Read more

Press / media

 

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

Events

 

The Fraunhofer IZI offers its partners and guests space for communication.

Utilize our modern and representative premises for your event. The generously proportioned and modern space offered at the Institute provides space for, e. g., workshops, symposia, conferences and lectures.

 

 

United against Corona

 

West Nile Virus on the rise in Europe

The European Centre for Disease Prevention and Control has been recording the rising spread of the virus in Europe and its neighboring countries for many years now.

 

Annual report 2019

The annual report gives you an insight into the structure of the Fraunhofer IZI, our services, important events and publications, offers, as well as selected project examples.

Research projects funded by the EU

Research projects at Fraunhofer IZI that are supported by the Land of Saxony / Saxony-Anhalt / Mecklenburg-Western Pomerania using funds provided by the European Regional Development Fund (ERDF).

 

Business units and core competencies

The Fraunhofer IZI offers R&D services for pharmaceutical, biotechnological and medical technology companies as well as for partners from research institutions, hospitals and diagnostic laboratories.

Jobs / career

We keep you informed on current job offers at the Fraunhofer IZI. Find out about the possibilities the Fraunhofer-Gesellschaft could offer you as an employer.

Publications

We gladly provide our clients and partners as well as the interested public with information on our research activities.

 

Contact

Fraunhofer IZI

 

Perlickstraße 1
04103 Leipzig
Germany

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000
E-mail info@izi.fraunhofer.de

 

Social Media